Business
Currency:USD
2025/Q1
Stock NameRevenueRatio
Pharmacology services13.07M92.95%
Other Translational Oncology Solutions (TOS) revenue992K7.05%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States50.16M100.00%